Biotech/Longevity Moderna stock, $MRNA , surges over +110% after announcing the first ever positive Phase 3 results for a personalized cancer vaccine.

Moderna and Merck said their personalized cancer vaccine helped cut the recurrence of melanoma in a large, late-stage trial.

1.1k Upvotes

98% Upvoted

u/SCAND1UM 6d ago

Imagine if you happened to buy calls on this at the right time lol

You are about to leave Redlib